Potent Inhibition of Macrophage Responses to IFN-γ by Live Virulent Mycobacterium tuberculosis Is Independent of Mature Mycobacterial Lipoproteins but Dependent on TLR21

Mycobacterium tuberculosis is a highly successful pathogen that can persist and cause disease despite an immune response. One potential mechanism for resisting elimination is by inhibiting the action of IFN-γ. We have previously shown that live M. tuberculosis inhibits selected macrophage responses to IFN-γ, and that purified M. tuberculosis 19-kDa lipoprotein inhibits induction of selected IFN-γ-responsive genes through a TLR2-dependent pathway, whereas peptidoglycan inhibits responses to IFN-γ by a TLR2-independent pathway. To determine the relative contribution of lipoproteins to the inhibition of responses to IFN-γ, we deleted the M. tuberculosis gene (lspA) that encodes lipoprotein signal peptidase. This revealed that M. tuberculosis lipoprotein processing is indispensable for stimulation of TLR2 reporter cells, but that the lspA mutant inhibits macrophage responses to IFN-γ to the same extent as wild-type bacteria. Macrophages lacking TLR2 are more resistant to inhibition by either strain of M. tuberculosis, suggesting that nonlipoprotein TLR2 agonists contribute to inhibition. Indeed, we found that phosphatidylinositol mannan from M. tuberculosis inhibits macrophage responses to IFN-γ. M. tuberculosis inhibition of responses to IFN-γ requires new protein synthesis, indicating that a late effect of innate immune stimulation is the inhibition of responses to IFN-γ. These results establish that M. tuberculosis possesses multiple mechanisms of inhibiting responses to IFN-γ.

[1]  I. Sutcliffe,et al.  Lipoproteins of Mycobacterium tuberculosis: an abundant and functionally diverse class of cell envelope components. , 2004, FEMS microbiology reviews.

[2]  D. Philpott,et al.  Toll‐like receptor 2‐dependent bacterial sensing does not occur via peptidoglycan recognition , 2004, EMBO reports.

[3]  John T. Belisle,et al.  Mycobacterium tuberculosis LprG (Rv1411c): A Novel TLR-2 Ligand That Inhibits Human Macrophage Class II MHC Antigen Processing1 , 2004, The Journal of Immunology.

[4]  S. Ehlers,et al.  Lipoprotein processing is required for virulence of Mycobacterium tuberculosis † , 2004, Molecular microbiology.

[5]  S. Fortune,et al.  Mycobacterium tuberculosis Inhibits Macrophage Responses to IFN-γ through Myeloid Differentiation Factor 88-Dependent and -Independent Mechanisms1 , 2004, The Journal of Immunology.

[6]  C. Harding,et al.  Inhibition of Major Histocompatibility Complex II Expression and Antigen Processing in Murine Alveolar Macrophages by Mycobacterium bovis BCG and the 19-Kilodalton Mycobacterial Lipoprotein , 2004, Infection and Immunity.

[7]  L. Kremer,et al.  Mycobacterium tuberculosis Lipomannan Induces Apoptosis and Interleukin-12 Production in Macrophages , 2004, Infection and Immunity.

[8]  L. Kremer,et al.  Toll-Like Receptor 2 (TLR2)-Dependent-Positive and TLR2-Independent-Negative Regulation of Proinflammatory Cytokines by Mycobacterial Lipomannans1 , 2004, The Journal of Immunology.

[9]  Jennifer Y. Zhang,et al.  Innate Inhibition of Adaptive Immunity: Mycobacterium tuberculosis-Induced IL-6 Inhibits Macrophage Responses to IFN-γ 1 , 2003, The Journal of Immunology.

[10]  S. Akira,et al.  MyD88 Primes Macrophages for Full-Scale Activation by Interferon-γ yet Mediates Few Responses to Mycobacterium tuberculosis , 2003, The Journal of experimental medicine.

[11]  J. Ernst,et al.  Mycobacterium tuberculosis Exerts Gene-Selective Inhibition of Transcriptional Responses to IFN-γ Without Inhibiting STAT1 Function1 , 2003, The Journal of Immunology.

[12]  S. Akira,et al.  Simultaneous Blocking of Human Toll-Like Receptors 2 and 4 Suppresses Myeloid Dendritic Cell Activation Induced by Mycobacterium bovis Bacillus Calmette-Guérin Peptidoglycan , 2003, Infection and Immunity.

[13]  C. Harding,et al.  The Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and FcγR1 on Human Macrophages through Toll-Like Receptor 2 , 2003, Infection and Immunity.

[14]  C. Harding,et al.  Inhibition of IFN-γ-Induced Class II Transactivator Expression by a 19-kDa Lipoprotein from Mycobacterium tuberculosis: A Potential Mechanism for Immune Evasion1 , 2003, The Journal of Immunology.

[15]  Yu-Jin Jung,et al.  Virulent but not Avirulent Mycobacterium tuberculosis Can Evade the Growth Inhibitory Action of a T Helper 1–dependent, Nitric Oxide Synthase 2–independent Defense in Mice , 2002, The Journal of experimental medicine.

[16]  W. Jacobs,et al.  Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. , 2002, Microbiology.

[17]  S. Akira,et al.  Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins1 , 2002, The Journal of Immunology.

[18]  G. Amphlett,et al.  Distribution of IFN‐γ, IL‐4 and TNF‐α protein and CD8 T cells producing IL‐12p40 mRNA in human lung tuberculous granulomas , 2002 .

[19]  C. Harding,et al.  Processing of Mycobacterium tuberculosis Antigen 85B Involves Intraphagosomal Formation of Peptide–Major Histocompatibility Complex II Complexes and Is Inhibited by Live Bacilli that Decrease Phagosome Maturation , 2001, The Journal of experimental medicine.

[20]  M. Fenton,et al.  Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages , 2001, Annals of the rheumatic diseases.

[21]  T. Gingeras,et al.  Reprogramming of the Macrophage Transcriptome in Response to Interferon-γ and Mycobacterium tuberculosis , 2001, The Journal of experimental medicine.

[22]  S. Akira,et al.  Discrimination of bacterial lipoproteins by Toll-like receptor 6. , 2001, International immunology.

[23]  J. Belisle,et al.  Different Toll‐like receptor agonists induce distinct macrophage responses , 2001, Journal of leukocyte biology.

[24]  R. Wilkinson,et al.  Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. , 2001, American journal of respiratory and critical care medicine.

[25]  J. Bijlsma.  Diagnosis and nonsurgical management of osteoarthritis , 2001, Annals of the rheumatic diseases.

[26]  P. Rothman,et al.  SOCS proteins, regulators of intracellular signaling. , 2000, Immunity.

[27]  D. Golenbock,et al.  Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products* , 1999, The Journal of Biological Chemistry.

[28]  L. Ting,et al.  Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.

[29]  D. Golenbock,et al.  Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. , 1999, Journal of immunology.

[30]  M. Torres,et al.  Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. , 1998, The Journal of infectious diseases.

[31]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[32]  C. Harding,et al.  Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. , 1998, Cellular immunology.

[33]  H. Dockrell,et al.  Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[35]  J. Abrams,et al.  Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.

[36]  B. Bloom,et al.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.

[37]  H. Murray,et al.  Gamma interferon-activated human macrophages and Toxoplasma gondii, Chlamydia psittaci, and Leishmania donovani: antimicrobial role of limiting intracellular iron , 1991, Infection and immunity.

[38]  W. Jacobs,et al.  New use of BCG for recombinant vaccines , 1991, Nature.

[39]  S. Kaufmann,et al.  Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor , 1990, Infection and immunity.

[40]  S. Kaufmann,et al.  Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. , 1987, Journal of immunology.

[41]  B. Champion,et al.  Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. , 1986, Immunology.

[42]  A. J. Crowle,et al.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria , 1985, Infection and immunity.

[43]  C. Nathan,et al.  Activation of human macrophages. Comparison of other cytokines with interferon-gamma , 1984, The Journal of experimental medicine.

[44]  C. Nathan,et al.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.

[45]  L. Kremer,et al.  Toll-Like Receptor 2 (TLR2)-Dependent-Positive and TLR2-Independent-Negative Regulation of Proinflammatory Cytokines by Mycobacterial Lipomannans , 2004 .

[46]  D. Golenbock,et al.  Toll-Like Receptor 2-Dependent Inhibition of Macrophage Class II MHC Expression and Antigen Processing by 19-kDa Lipoprotein of Mycobacterium tuberculosis , 2001 .

[47]  Malin,et al.  Human cytolytic and interferon g-secreting CD 8 1 T lymphocytes specific for Mycobacterium tuberculosis , 1997 .

[48]  P. Randhawa,et al.  Lymphocyte subsets in granulomas of human tuberculosis: An in situ immunofluorescence study using monoclonal antibodies , 1990, Pathology.

[49]  A. Pugsley.  Molecular genetics in mycobacteria. , 1987, Microbiological sciences.